we investigated the immunogenicity of human proinsulin ( hpi ) when used as the sole or principal insulin agonist in insulin-naive patients with insulin-dependent ( type i ) and non-insulin-dependent ( type ii ) diabetes mellitus .
C0033362
proinsulin
C0021641
insulin